Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...

Blood thinners prescribed after blood clots in the leg or lung initially increase the risk of bleeding, especially in women ...

According to research presented at the EAHAD 2024 Annual Congress, a new classification system enhances diagnosis and ...

According to research presented at the EAHAD 2024 Annual Congress, miRNA signatures show promise as biomarkers for hemophilic ...

Columnist Alliah Czarielle doesn't want a person with an invisible disability to be perceived by businesses as a fraud.